Treatment considerations for patients with pemphigus during the COVID-19 pandemic

Схожие документы

• Authors' reply to the comment “Treatment considerations for patients with pemphigus during the COVID-19 pandemic”
  по: Shakshouk, Hadir, et al.
  Опубликовано: (2021)
• Reply to “Treatment considerations for patients with pemphigus during the COVID-19 pandemic”
  по: Schultz, Brittney, et al.
  Опубликовано: (2021)
• Treatment concerns for bullous pemphigoid in the COVID‐19 pandemic era
  по: Azimi, Seyyede Zeinab, et al.
  Опубликовано: (2020)
• Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: Safety considerations
  по: Blaszczak, Alecia, et al.
  Опубликовано: (2020)
• Reply to: “Biologics for psoriasis during COVID-19 outbreak”
  по: Murrell, Dedee F., et al.
  Опубликовано: (2020)